Science Explorer Back to mapMap
Discussion
Company · Portsmouth · United States

Novocure (United States)

novocure.comROR OpenAlex
World rank, 2022-now
#22,025
of 22,385 · #33,360 all time
Rank in United States
#3,268
of 3,332
Research works
162
▲ 3% vs 2018-21
Citations
1.7k
10.2 per fractional work
Top-10% rate
8.8%
all institutions 10.0%
vs its own fields
0.93×
1.00× is exactly expected
Open access
65%
world 40%
International
21%
world 18%
Novocure (United States)

Which fields of science does Novocure (United States) work in?

In 2022-now, 51% of research at Novocure (United States) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (15%), Engineering (10%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 36 fractional works · 51.3% of its workMedicine: 36 fractional works · 50.9% of its workPulmonary and Respiratory Medicine: 11 fractional works · 15.6% of its workGenetics: 9 fractional works · 12.5% of its workOncology: 5 fractional works · 6.7% of its workRadiology, Nuclear Medicine and Imaging: 5 fractional works · 6.5% of its workEpidemiology: 1 fractional works · 2.0% of its workReproductive Medicine: 1 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.7% of its workSurgery: 1 fractional works · 1.1% of its workPhysiology: 0 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.8% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workLife Sciences: 16 fractional works · 22.8% of its workBiochemistry, Genetics and Molecular Biology: 11 fractional works · 15.1% of its workBiotechnology: 4 fractional works · 6.3% of its workMolecular Biology: 3 fractional works · 4.8% of its workBiophysics: 1 fractional works · 1.7% of its workCancer Research: 1 fractional works · 1.3% of its workCell Biology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.3% of its workImmunology and Microbiology: 3 fractional works · 3.7% of its workImmunology: 2 fractional works · 3.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 2.1% of its workPharmaceutical Science: 2 fractional works · 2.1% of its workNeuroscience: 1 fractional works · 2.0% of its workNeurology: 1 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.6% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 11 fractional works · 16.0% of its workEngineering: 7 fractional works · 9.5% of its workBiomedical Engineering: 5 fractional works · 7.4% of its workElectrical and Electronic Engineering: 1 fractional works · 1.0% of its workMechanical Engineering: 0 fractional works · 0.7% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 2 fractional works · 2.2% of its workOrganic Chemistry: 2 fractional works · 2.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 1.5% of its workMaterials Chemistry: 1 fractional works · 1.0% of its workBiomaterials: 0 fractional works · 0.4% of its workComputer Science: 1 fractional works · 1.0% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workHardware and Architecture: 0 fractional works · 0.2% of its workMathematics: 1 fractional works · 1.0% of its workModeling and Simulation: 1 fractional works · 1.0% of its workPhysics and Astronomy: 0 fractional works · 0.7% of its workRadiation: 0 fractional works · 0.7% of its workEnergy: 0 fractional works · 0.2% of its workSocial Sciences: 7 fractional works · 9.9% of its workEconomics, Econometrics and Finance: 7 fractional works · 9.3% of its workEconomics and Econometrics: 7 fractional works · 9.3% of its workPsychology: 0 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.5% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workALL ITS WORKNovocure (UnitedStates)70fractional works, 2022-now
Life Sciences23%Physical Sciences16%Health Sciences51%Social Sciences10%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine3650.9%
    2. Nursing00.4%
    1. Biochemistry, Genetics and Molecular Biology1115.1%
    2. Immunology and Microbiology33.7%
    3. Pharmacology, Toxicology and Pharmaceutics22.1%
    4. Neuroscience12.0%
    1. Engineering79.5%
    2. Chemistry22.2%
    3. Materials Science11.5%
    4. Computer Science11.0%
    5. Mathematics11.0%
    6. Physics and Astronomy00.7%
    7. Energy00.2%
    1. Economics, Econometrics and Finance79.3%
    2. Psychology00.5%
    3. Business, Management and Accounting00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.82× its world share, 11 worksBiochemistry, Geneti…Immunology and Microbiology: 3.64× its world share, 3 worksImmunology and Micro…Neuroscience: 1.22× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.04× its world share, 2 worksPharmacology, Toxico…Chemistry: 1.42× its world share, 2 worksChemistryComputer Science: 0.12× its world share, 1 worksComputer ScienceEnergy: 0.17× its world share, 0 worksEnergyEngineering: 0.64× its world share, 7 worksEngineeringMaterials Science: 0.42× its world share, 1 worksMaterials ScienceMathematics: 0.80× its world share, 1 worksMathematicsPhysics and Astronomy: 0.32× its world share, 0 worksPhysics and AstronomyMedicine: 2.65× its world share, 36 worksMedicineNursing: 0.72× its world share, 0 worksNursingBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 4.37× its world share, 7 worksEconomics, Econometr…Psychology: 0.16× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.0×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics6.04×2 works
  2. Economics, Econometrics and Finance4.37×7 works
  3. Immunology and Microbiology3.64×3 works
  4. Biochemistry, Genetics and Molecular Biology2.82×11 works
  5. Medicine2.65×36 works
  6. Chemistry1.42×2 works
  7. Neuroscience1.22×1 works
  8. Mathematics0.80×1 works
  9. Nursing0.72×0 works
  10. Engineering0.64×7 works
  11. Materials Science0.42×1 works
  12. Physics and Astronomy0.32×0 works
  13. Energy0.17×0 works
  14. Psychology0.16×0 works
  15. Computer Science0.12×1 works
  16. Business, Management and Accounting0.02×0 works

Who are the top researchers at Novocure (United States)?

Ranked on the quality score, Rosa S. Schneiderman, Boris Brant and Anna Shteingauz lead among researchers whose main affiliation is Novocure (United States).

  1. 1 Rosa S. Schneiderman United States · #734,670 worldwide 5.1k citations · 130 works
  2. 2 Boris Brant United States · #960,558 worldwide 317 citations · 54 works
  3. 3 Anna Shteingauz United States · #969,351 worldwide 1.4k citations · 86 works
  4. 4 Catherine Tempel-Brami United States · #979,392 worldwide 626 citations · 45 works
  5. 5 Eilon David Kirson United States · #1,087,223 worldwide 11k citations · 216 works
  6. 6 Yoram Palti United States · #1,164,655 worldwide 12k citations · 341 works
  7. 7 Shay Cahal United States · #1,226,154 worldwide 967 citations · 59 works
  8. 8 Tal Kan United States · #1,277,676 worldwide 349 citations · 46 works
  9. 9 Tali Voloshin United States · #1,285,419 worldwide 2.1k citations · 178 works
  10. 10 Uri Weinberg United States · #1,303,073 worldwide 8.2k citations · 276 works
All ranked researchers at Novocure (United States)

What are the most cited papers from Novocure (United States)?

The most cited paper from Novocure (United States) is "NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality" (Roger Stupp et al., 2012), with 863 citations. Next come "Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells" (326) and "Tumor treating fields: a new frontier in cancer therapy" (195).

Most cited papers
#PaperReleasedCitations
1 NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality Roger Stupp et al. · European Journal of Cancer Open access 17 May 2012 863
2 Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells Moshe Giladi, Rosa S. Schneiderman, Tali Voloshin et al. · Scientific Reports Open access 11 Dec 2015 326
3 Tumor treating fields: a new frontier in cancer therapy Angela M. Davies, Uri Weinberg, Yoram Palti · Annals of the New York Academy of Sciences 9 May 2013 195
4 Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR -Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors Jörg Felsberg, Bettina Hentschel, Kerstin Kaulich et al. · Clinical Cancer Research Open access 29 Aug 2017 188
5 Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy Tali Voloshin, Noa Kaynan, Shiri Davidi et al. · Cancer Immunology Immunotherapy Open access 6 Mar 2020 180
All 65 most cited papers, with filters and sorting

Which keywords describe research at Novocure (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Radiotherapy, Molecular Classification, Glioblastoma, Temozolomide, Clinical Trials, Targeted Therapy and Chemotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy17▲ 34×11 topics
  2. Radiotherapy12▲ 42×4 topics
  3. Glioblastoma9▲ 184×1 topic
  4. Molecular Classification9▲ 82×2 topics
  5. Temozolomide9▲ 184×1 topic
  6. Clinical Trials8▲ 17×5 topics
  7. Targeted Therapy7▲ 47×4 topics
  8. Chemotherapy6▲ 12×10 topics
  9. Gene Therapy5▲ 36×4 topics
  10. ALK Inhibitors5▲ 110×1 topic
  11. EGFR Mutations5▲ 110×1 topic
  12. Tumor Targeting5▲ 36×3 topics
  13. Quality of Life4▲ 4.0×2 topics
  14. Cancer4▲ 4.0×11 topics
  15. Regenerative Medicine4▲ 20×3 topics
  16. Cost-effectiveness Analysis4▲ 62×1 topic
  17. Economic Evaluation4▲ 42×2 topics
  18. Health Utility Measures4▲ 62×1 topic
  19. Tumor Regression4▲ 45×2 topics
  20. Arginine Deprivation3▲ 126×1 topic
  21. Bacterial Therapy3▲ 126×1 topic
  22. Tissue Engineering3▲ 7.4×3 topics
  23. Cancer Treatment3▲ 18×6 topics
  24. Bioprinting3▲ 70×1 topic
  25. Medicinal Chemistry3▲ 16×5 topics
  26. Microfluidic Devices3▲ 35×1 topic
  27. Tumor Microenvironment3▲ 8.5×4 topics
  28. Biomarkers3▲ 5.3×4 topics
  29. Cost of Care3▲ 122×1 topic
  30. Financial Toxicity3▲ 122×1 topic
  31. Metastasis3▲ 11×3 topics
  32. Immunity2▲ 7.7×4 topics
  33. Feature Extraction2▲ 6.4×2 topics
  34. Medical Imaging2▲ 5.5×2 topics
  35. Metabolism2▲ 5.4×4 topics
  36. Prognostic Factors2▲ 6.5×4 topics
  37. Clinical Applications2▲ 42×2 topics
  38. Cognitive Function2▲ 14×2 topics
  39. Radiosurgery2▲ 28×2 topics
  40. Brain Metastases2▲ 87×1 topic

Which research topics does Novocure (United States) publish most on?

By volume in 2022-now: Glioma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Health Systems, Economic Evaluations, Quality of Life and Cancer Research and Treatments.

Glioma Diagnosis and Tre…9Glioma Diagnosis and Treatment: 9 fractional worksLung Cancer Treatments a…5Lung Cancer Treatments and Mutations: 5 fractional worksHealth Systems, Economic…4Health Systems, Economic Evaluations, Quality of Life: 4 fractional worksCancer Research and Treatments: 3 fractional works3D Printing in Biomedical Research: 3 fractional worksEconomic and Financial I…3Economic and Financial Impacts of Cancer: 3 fractional worksBrain Metastases and Treatment: 2 fractional worksImmune cells in cancer: 2 fractional worksRadiomics and Machine Learning in Medical Imaging: 2 fractional worksRadiation Therapy and Dosimetry: 2 fractional works
GeneticsPulmonary and Respiratory MedicineEconomics and EconometricsBiotechnology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Glioma Diagnosis and Treatment Genetics 9 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  4. 4 Cancer Research and Treatments Biotechnology 3 works
  5. 5 3D Printing in Biomedical Research Biomedical Engineering 3 works
  6. 6 Economic and Financial Impacts of Cancer Economics and Econometrics 3 works
  7. 7 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 2 works
  8. 8 Immune cells in cancer Immunology 2 works
  9. 9 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
  10. 10 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.9%not open35.1%

World: 40% of research is openly available.

with international co-authors20.8%domestic only79.2%

World: 18% is written across borders.

How has Novocure (United States)'s research output changed?

Output in 2022-2025 was 3% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Novocure (United States) as a percentage of every work published that year, 0.00017% in 2024.

still counting0.00020%0.00040%0.00060%Novocure (United States)0.00033% in 2025200020102020

Fractional works of Novocure (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Portsmouth

All research institutions in Portsmouth

Share Novocure (United States)'s ranking

Novocure (United States) on Science Explorer

A card with Novocure (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Novocure (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.